Pharmaceuticals, Biotechnology and Life Sciences
Progenity has named new Chief Commercial Officer, boosting its capacity in executive leadership team.
Phillips-Medisize has won a contract to produce first electronic-enabled combination drug delivery product, which is a post-phase 3 developement stage…
RALEIGH, N.C.–(BUSINESS WIRE)– SignalPath, a healthcare technology company reimagining the execution of clinical trials, announces the closing of their Series…
PRINCETON, N.J. & SAN DIEGO–(BUSINESS WIRE)–Sonnet BioTherapeutics Inc., a clinical stage biopharmaceutical developing innovative targeted biologic drugs, announced today that…
SCOTTSDALE, Ariz.–(BUSINESS WIRE)–#AI— Systems Oncology, LLC (“SO”) and The Pritzker Organization, LLC (“TPO”) announced today that Pritzker Family Business Interests…
NOTTINGHAM, England–(BUSINESS WIRE)–Quotient Sciences, the innovative drug development and manufacturing organization, today announces the appointment of Claes Glassell as non-executive…
More than $2.9 million in funding will support clinical trials to study virtual reality platforms as a therapeutic alternative for…
Top line results are expected to be available in February 2020 GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc. (OTCQB: CTDH), formerly CTD…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a biotechnology company focused on drugging the human immune synapse to treat human diseases, today announced…
CVL-231 has the potential to be the first novel mechanism of action in schizophrenia in over two decades BOSTON–(BUSINESS WIRE)–Cerevel…